CCOC(=O)CC[C@H](NC(=O)c1nc[nH]c1/N=N/N(C)C)C(=O)OCC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?